Derleme
Yıl 2017,
Cilt: 5 Sayı: 4, 37 - 40, 10.04.2017
Öz
Abstract
Today management of type 1 Diabetes Mellitus (DM) consists of intensive insulintherapy combined with lifestyle and dietary interventions, exercise, patient education,follow-up of complications, and psychosocial support. Intensive diabetes treatment mayrepresent some challenges to both patients and physicians. Increased need for frequent follow-up, risk of hypoglycemia, increased weight gain, and increased cost as compared to older regimens are some of these. Conversely, due to the fact that intensive insulin therapy mimics physiological insulin secretion and the demonstrated efficacy, it isnow the standard approach in type 1 DM treatment.
Kaynakça
- Kaynaklar 1.Böber E, Abacı A. TİP 1 Diyabet-Derleme. The Journal of CurrentPediatrics. 2007;5:1-10. 2.Abacı A, Böber E, Büyükgebiz A. Tip 1 Diyabetin Uzun Dönem İz-lemi - Derleme. The Journal of Current Pediatrics. 2008;6:111-8. 3.Kyi M, Wentworth JM, Nankervis AJ, Fourlanos S, Colman PG. Re-cent advances in type 1 diabetes. The Medical journal of Australia.2015;203(7):290-3. Epub 2015/10/02. PubMed PMID: 26424063. 4.Reddy M, Rilstone S, Cooper P, Oliver NS. Type 1 diabetes in adults:supporting self management. BMJ (Clinical research ed).2016;352:i998. Epub 2016/03/12. doi: 10.1136/bmj.i998. PubMedPMID: 26965473. 5.Standards of medical care in diabetes--2009. Diabetes care. 2009;32Suppl 1:S13-61. Epub 2009/01/06. doi: 10.2337/dc09-S013. PubMedPMID: 19118286; PubMed Central PMCID: PMCPMC2613589. 6.Mesa J. [New insulin types in type 1 diabetes mellitus]. Medicina cli-nica. 2015;145(2):70-5. Epub 2014/09/10. doi: 10.1016/j.medc-li.2014.04.024. PubMed PMID: 25200067. 7.Chatterjee S, Davies MJ. Current management of diabetes mellitusand future directions in care. Postgraduate medical journal.2015;91(1081):612-21. Epub 2015/10/11. doi: 10.1136/postgradmedj-2014-133200. PubMed PMID: 26453594. 8.Bell KJ, King BR, Shafat A, Smart CE. The relationship between car-bohydrate and the mealtime insulin dose in type 1 diabetes. Journalof diabetes and its complications. 2015;29(8):1323-9. Epub2015/10/01. doi: 10.1016/j.jdiacomp.2015.08.014. PubMed PMID:26422396. 9.Control TD, Group CTR. The Effect of Intensive Treatment of Dia-betes on the Development and Progression of Long-Term Compli-cations in Insulin-Dependent Diabetes Mellitus. New England Jo-urnal of Medicine. 1993;329(14):977-86. doi: doi:10.1056/NEJM199309303291401. PubMed PMID: 8366922. 10.Epidemiology of Diabetes Interventions and Complications (EDIC).Design, implementation, and preliminary results of a long-term fol-low-up of the Diabetes Control and Complications Trial cohort. Dia-betes care. 1999;22(1):99-111. Epub 1999/05/20. PubMed PMID:10333910; PubMed Central PMCID: PMCPMC2745938. 11.Joshi M, Choudhary P. Multiple Daily Injections OR Insulin PumpTherapy: Choosing the Best Option for Your Patient-An Evidence-based Approach. Current diabetes reports. 2015;15(10):81. Epub2015/09/05. doi: 10.1007/s11892-015-0644-z. PubMed PMID:26338287. 12.King AB, Kuroda A, Matsuhisa M, Hobbs T. A Review of Insulin-Do-sing Formulas for Continuous Subcutaneous Insulin Infusion (CSII)for Adults with Type 1 Diabetes. Current diabetes reports.2016;16(9):83. Epub 2016/07/28. doi: 10.1007/s11892-016-0772-0. PubMed PMID: 27457238; PubMed Central PMCID:PMCPMC4960276. 13.Jeitler K, Horvath K, Berghold A, Gratzer TW, Neeser K, Pieber TR,et al. Continuous subcutaneous insulin infusion versus multiple da-ily insulin injections in patients with diabetes mellitus: systematic re-view and meta-analysis. Diabetologia. 2008;51(6):941-51. Epub2008/03/21. doi: 10.1007/s00125-008-0974-3. PubMed PMID:18351320. 14.Fatourechi MM, Kudva YC, Murad MH, Elamin MB, Tabini CC, Mon-tori VM. Clinical review: Hypoglycemia with intensive insulin the-rapy: a systematic review and meta-analyses of randomized trials ofcontinuous subcutaneous insulin infusion versus multiple daily in-jections. The Journal of clinical endocrinology and metabolism.2009;94(3):729-40. Epub 2008/12/18. doi: 10.1210/jc.2008-1415.PubMed PMID: 19088167. 15.Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic controlin Type 1 diabetes: meta-analysis of multiple daily insulin injecti-ons compared with continuous subcutaneous insulin infusion. Dia-betic medicine : a journal of the British Diabetic Association.2008;25(7):765-74. Epub 2008/07/23. doi: 10.1111/j.1464-5491.2008.02486.x. PubMed PMID: 18644063. 16.Pozzilli P, Battelino T, Danne T, Hovorka R, Jarosz-Chobot P, Re-nard E. Continuous subcutaneous insulin infusion in diabetes: pa-tient populations, safety, efficacy, and pharmacoeconomics. Diabe-tes/metabolism research and reviews. 2016;32(1):21-39. Epub2015/04/14. doi: 10.1002/dmrr.2653. PubMed PMID: 25865292; Pub-Med Central PMCID: PMCPMC5033023. 17.Ejaz S, Wilson T. Managing type 1 diabetes a journey from starva-tion to insulin pump. Minerva endocrinologica. 2013;38(2): 123-31. Epub 2013/06/05. PubMed PMID: 23732367. 18.Knapp S, Manroa P, Doshi K. Self-monitoring of blood glucose: Ad-vice for providers and patients. Cleveland Clinic journal of medicine. 2016;83(5):355-60. Epub 2016/05/12. doi: 10.3949/ccjm.83a.14147. PubMed PMID: 27168511. 19.Wascher TC, Stechemesser L. [Blood glucose self monitoring]. Wie-ner klinische Wochenschrift. 2016;128 Suppl 2:S137-40. Epub2016/04/08. doi: 10.1007/s00508-015-0927-z. PubMed PMID:27052233. 20.Institute for Q, Efficiency in Health C. IQWiG Executive Summari-es of Final Reports. Continuous Interstitial Glucose Monitoring(CGM) with Real-Time Measurement Devices in Insulin-DependentDiabetes Mellitus. Cologne, Germany: Institute for Quality and Ef-ficiency in Health Care (IQWiG)Copyright (c) 2015 by the Institute for Quality and Efficiency in Health-care (IQWiG). 2015. 21.Weitgasser R, Clodi M, Cvach S, Grafinger P, Lechleitner M, Ho-worka K, et al. [Diabetes education in adult diabetic patients]. Wie-ner klinische Wochenschrift. 2016;128 Suppl 2:S146-50. Epub2016/04/08. doi: 10.1007/s00508-015-0935-z. PubMed PMID:27052242. 22.Martin M, Krystof S, Jiri R, Martina D, Renata V, Ondrej M, et al.Modulation of Energy Intake and Expenditure Due to Habitual Physi-cal Exercise. Current pharmaceutical design. 2016;22(24):3681-99.Epub 2016/04/20. PubMed PMID: 27090792. 23.Tully C, Aronow L, Mackey E, Streisand R. Physical Activity in Yo-uth With Type 1 Diabetes: a Review. Current diabetes reports.2016;16(9):85. Epub 2016/08/01. doi: 10.1007/s11892-016-0779-6. PubMed PMID: 27475093. 24.Davey RJ, Bussau VA, Paramalingam N, Ferreira LD, Lim EM, Da-vis EA, et al. A 10-s sprint performed after moderate-intensity exer-cise neither increases nor decreases the glucose requirement to pre-vent late-onset hypoglycemia in individuals with type 1 diabetes. Dia-betes care. 2013;36(12):4163-5. Epub 2013/10/17. doi: 10.2337/dc12-2198. PubMed PMID: 24130362; PubMed Central PMCID:PMCPMC3836164. 25.Zoffmann V, Vistisen D, Due-Christensen M. A cross-sectional studyof glycaemic control, complications and psychosocial functioningamong 18- to 35-year-old adults with type 1 diabetes. Diabetic me-dicine : a journal of the British Diabetic Association. 2014;31(4):493-9. Epub 2013/11/19. doi: 10.1111/dme.12363. PubMed PMID:24236961. 26.Lifetime benefits and costs of intensive therapy as practiced in thediabetes control and complications trial. The Diabetes Control andComplications Trial Research Group. Jama. 1996;276(17):1409-15.Epub 1996/11/06. PubMed PMID: 8892716. 27.Egger M, Davey Smith G, Stettler C, Diem P. Risk of adverse effectsof intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis. Diabetic medicine : a journal of the British Diabetic As-sociation. 1997;14(11):919- 28. Epub 1997/12/24. doi:10.1002/(sici)1096-9136(199711)14:11<919::aid-dia456>3.0.co;2-a. PubMed PMID: 9400915.
Yıl 2017,
Cilt: 5 Sayı: 4, 37 - 40, 10.04.2017
Öz
Öz
Günümüzde tip 1 Diabetes Mellitus (DM) tedavisi yoğun insülin tedavisi ve bununyaşam tarzı, diyet, egzersiz, hasta eğitimi, komplikasyonların takibi ve psikososyal destek gibi öğelerle desteklenmesini içermektedir. Yoğun diyabet tedavisi hem hasta hemde hekim açısından bazı zorluklar içerebilir. Hastaların sık takip gerekliliği ve artmış hipoglisemi riski, eski rejimlere oranla kilo artışının daha fazla görülebilmesi ve artmış maliyet bunlardan bazılarıdır. Buna karşın fizyolojik insülin salgısını en iyi taklit eden re-jim olması ve gösterilmiş etkinliği nedeniyle yoğun diyabet tedavisi günümüzde tip 1DM tedavisinde standart yaklaşımdır.
Kaynakça
- Kaynaklar 1.Böber E, Abacı A. TİP 1 Diyabet-Derleme. The Journal of CurrentPediatrics. 2007;5:1-10. 2.Abacı A, Böber E, Büyükgebiz A. Tip 1 Diyabetin Uzun Dönem İz-lemi - Derleme. The Journal of Current Pediatrics. 2008;6:111-8. 3.Kyi M, Wentworth JM, Nankervis AJ, Fourlanos S, Colman PG. Re-cent advances in type 1 diabetes. The Medical journal of Australia.2015;203(7):290-3. Epub 2015/10/02. PubMed PMID: 26424063. 4.Reddy M, Rilstone S, Cooper P, Oliver NS. Type 1 diabetes in adults:supporting self management. BMJ (Clinical research ed).2016;352:i998. Epub 2016/03/12. doi: 10.1136/bmj.i998. PubMedPMID: 26965473. 5.Standards of medical care in diabetes--2009. Diabetes care. 2009;32Suppl 1:S13-61. Epub 2009/01/06. doi: 10.2337/dc09-S013. PubMedPMID: 19118286; PubMed Central PMCID: PMCPMC2613589. 6.Mesa J. [New insulin types in type 1 diabetes mellitus]. Medicina cli-nica. 2015;145(2):70-5. Epub 2014/09/10. doi: 10.1016/j.medc-li.2014.04.024. PubMed PMID: 25200067. 7.Chatterjee S, Davies MJ. Current management of diabetes mellitusand future directions in care. Postgraduate medical journal.2015;91(1081):612-21. Epub 2015/10/11. doi: 10.1136/postgradmedj-2014-133200. PubMed PMID: 26453594. 8.Bell KJ, King BR, Shafat A, Smart CE. The relationship between car-bohydrate and the mealtime insulin dose in type 1 diabetes. Journalof diabetes and its complications. 2015;29(8):1323-9. Epub2015/10/01. doi: 10.1016/j.jdiacomp.2015.08.014. PubMed PMID:26422396. 9.Control TD, Group CTR. The Effect of Intensive Treatment of Dia-betes on the Development and Progression of Long-Term Compli-cations in Insulin-Dependent Diabetes Mellitus. New England Jo-urnal of Medicine. 1993;329(14):977-86. doi: doi:10.1056/NEJM199309303291401. PubMed PMID: 8366922. 10.Epidemiology of Diabetes Interventions and Complications (EDIC).Design, implementation, and preliminary results of a long-term fol-low-up of the Diabetes Control and Complications Trial cohort. Dia-betes care. 1999;22(1):99-111. Epub 1999/05/20. PubMed PMID:10333910; PubMed Central PMCID: PMCPMC2745938. 11.Joshi M, Choudhary P. Multiple Daily Injections OR Insulin PumpTherapy: Choosing the Best Option for Your Patient-An Evidence-based Approach. Current diabetes reports. 2015;15(10):81. Epub2015/09/05. doi: 10.1007/s11892-015-0644-z. PubMed PMID:26338287. 12.King AB, Kuroda A, Matsuhisa M, Hobbs T. A Review of Insulin-Do-sing Formulas for Continuous Subcutaneous Insulin Infusion (CSII)for Adults with Type 1 Diabetes. Current diabetes reports.2016;16(9):83. Epub 2016/07/28. doi: 10.1007/s11892-016-0772-0. PubMed PMID: 27457238; PubMed Central PMCID:PMCPMC4960276. 13.Jeitler K, Horvath K, Berghold A, Gratzer TW, Neeser K, Pieber TR,et al. Continuous subcutaneous insulin infusion versus multiple da-ily insulin injections in patients with diabetes mellitus: systematic re-view and meta-analysis. Diabetologia. 2008;51(6):941-51. Epub2008/03/21. doi: 10.1007/s00125-008-0974-3. PubMed PMID:18351320. 14.Fatourechi MM, Kudva YC, Murad MH, Elamin MB, Tabini CC, Mon-tori VM. Clinical review: Hypoglycemia with intensive insulin the-rapy: a systematic review and meta-analyses of randomized trials ofcontinuous subcutaneous insulin infusion versus multiple daily in-jections. The Journal of clinical endocrinology and metabolism.2009;94(3):729-40. Epub 2008/12/18. doi: 10.1210/jc.2008-1415.PubMed PMID: 19088167. 15.Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic controlin Type 1 diabetes: meta-analysis of multiple daily insulin injecti-ons compared with continuous subcutaneous insulin infusion. Dia-betic medicine : a journal of the British Diabetic Association.2008;25(7):765-74. Epub 2008/07/23. doi: 10.1111/j.1464-5491.2008.02486.x. PubMed PMID: 18644063. 16.Pozzilli P, Battelino T, Danne T, Hovorka R, Jarosz-Chobot P, Re-nard E. Continuous subcutaneous insulin infusion in diabetes: pa-tient populations, safety, efficacy, and pharmacoeconomics. Diabe-tes/metabolism research and reviews. 2016;32(1):21-39. Epub2015/04/14. doi: 10.1002/dmrr.2653. PubMed PMID: 25865292; Pub-Med Central PMCID: PMCPMC5033023. 17.Ejaz S, Wilson T. Managing type 1 diabetes a journey from starva-tion to insulin pump. Minerva endocrinologica. 2013;38(2): 123-31. Epub 2013/06/05. PubMed PMID: 23732367. 18.Knapp S, Manroa P, Doshi K. Self-monitoring of blood glucose: Ad-vice for providers and patients. Cleveland Clinic journal of medicine. 2016;83(5):355-60. Epub 2016/05/12. doi: 10.3949/ccjm.83a.14147. PubMed PMID: 27168511. 19.Wascher TC, Stechemesser L. [Blood glucose self monitoring]. Wie-ner klinische Wochenschrift. 2016;128 Suppl 2:S137-40. Epub2016/04/08. doi: 10.1007/s00508-015-0927-z. PubMed PMID:27052233. 20.Institute for Q, Efficiency in Health C. IQWiG Executive Summari-es of Final Reports. Continuous Interstitial Glucose Monitoring(CGM) with Real-Time Measurement Devices in Insulin-DependentDiabetes Mellitus. Cologne, Germany: Institute for Quality and Ef-ficiency in Health Care (IQWiG)Copyright (c) 2015 by the Institute for Quality and Efficiency in Health-care (IQWiG). 2015. 21.Weitgasser R, Clodi M, Cvach S, Grafinger P, Lechleitner M, Ho-worka K, et al. [Diabetes education in adult diabetic patients]. Wie-ner klinische Wochenschrift. 2016;128 Suppl 2:S146-50. Epub2016/04/08. doi: 10.1007/s00508-015-0935-z. PubMed PMID:27052242. 22.Martin M, Krystof S, Jiri R, Martina D, Renata V, Ondrej M, et al.Modulation of Energy Intake and Expenditure Due to Habitual Physi-cal Exercise. Current pharmaceutical design. 2016;22(24):3681-99.Epub 2016/04/20. PubMed PMID: 27090792. 23.Tully C, Aronow L, Mackey E, Streisand R. Physical Activity in Yo-uth With Type 1 Diabetes: a Review. Current diabetes reports.2016;16(9):85. Epub 2016/08/01. doi: 10.1007/s11892-016-0779-6. PubMed PMID: 27475093. 24.Davey RJ, Bussau VA, Paramalingam N, Ferreira LD, Lim EM, Da-vis EA, et al. A 10-s sprint performed after moderate-intensity exer-cise neither increases nor decreases the glucose requirement to pre-vent late-onset hypoglycemia in individuals with type 1 diabetes. Dia-betes care. 2013;36(12):4163-5. Epub 2013/10/17. doi: 10.2337/dc12-2198. PubMed PMID: 24130362; PubMed Central PMCID:PMCPMC3836164. 25.Zoffmann V, Vistisen D, Due-Christensen M. A cross-sectional studyof glycaemic control, complications and psychosocial functioningamong 18- to 35-year-old adults with type 1 diabetes. Diabetic me-dicine : a journal of the British Diabetic Association. 2014;31(4):493-9. Epub 2013/11/19. doi: 10.1111/dme.12363. PubMed PMID:24236961. 26.Lifetime benefits and costs of intensive therapy as practiced in thediabetes control and complications trial. The Diabetes Control andComplications Trial Research Group. Jama. 1996;276(17):1409-15.Epub 1996/11/06. PubMed PMID: 8892716. 27.Egger M, Davey Smith G, Stettler C, Diem P. Risk of adverse effectsof intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis. Diabetic medicine : a journal of the British Diabetic As-sociation. 1997;14(11):919- 28. Epub 1997/12/24. doi:10.1002/(sici)1096-9136(199711)14:11<919::aid-dia456>3.0.co;2-a. PubMed PMID: 9400915.
Toplam 1 adet kaynakça vardır.
Ayrıntılar
| Birincil Dil | Türkçe |
|---|---|
| Bölüm | Makaleler 1 |
| Yazarlar | |
| Yayımlanma Tarihi | 10 Nisan 2017 |
| Yayımlandığı Sayı | Yıl 2017 Cilt: 5 Sayı: 4 |
